Evidence map›Paper›PMID 27464258›Full record

ArticleNano letters2016

Stable Radiolabeling of Sulfur-Functionalized Silica Nanoparticles with Copper-64.

Travis M Shaffer, Stefan Harmsen, Emaad Khwaja, Moritz F Kircher, Charles Michael Drain, Jan Grimm

Abstract read
In one paragraph

Article in Nano letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Marriage of black phosphorus and CuNature communications · 2020
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Recent Advances in Zirconium-89 Chelator Development.Molecules (Basel, Switzerland) · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Travis M ShafferMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center , New York, New York 10065, United States.
Stefan HarmsenDepartment of Radiology, Memorial Sloan Kettering Cancer Center , New York, New York 10065, United States.
Emaad KhwajaDepartment of Chemistry, Hunter College of the City University of New York , New York, New York 10065, United States.
Moritz F KircherDepartment of Radiology, Memorial Sloan Kettering Cancer Center , New York, New York 10065, United States.
Charles Michael DrainDepartment of Chemistry, Hunter College of the City University of New York , New York, New York 10065, United States.
Jan GrimmMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center , New York, New York 10065, United States.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Tumor Hypoxia Imaging - Laboratory and Clinical StudiesP01CA115675 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI KOUTCHER, JASON ARTHUR · 2006 to 2010
$9.5M
Cerenkov luminescence imaging for image-guided cancer surgeryR01CA183953 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI GRIMM, JAN · 2015 to 2019
$2.6M
Cerenkov-emission based nanosensors to detect biologic activities in vivoR01EB014944 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI GRIMM, JAN · 2012 to 2015
$1.6M
MRI-Photoacoustic-Raman Nanostars for Pre- and Intraoperative Multimodal ImagingR01EB017748 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI KIRCHER, MORITZ FLORIAN · 2014 to 2017
$1.6M
Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-ModalityK08CA163961 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI KIRCHER, MORITZ FLORIAN · 2012 to 2016
$845k
The Ivis Spectrum CT for Pre-Clinical Oncology ResearchS10OD016207 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI ZANZONICO, PAT B · 2013 to 2013
$595k
NCI NIH HHS K08 CA163961NCI NIH HHS P01 CA115675NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA183953NIBIB NIH HHS R01 EB014944NIBIB NIH HHS R01 EB017748NIH HHS S10 OD016207
6 · The paper itself

Abstract

Nanoparticles labeled with radiometals enable whole-body nuclear imaging and therapy. Though chelating agents are commonly used to radiolabel biomolecules, nanoparticles offer the advantage of attaching a radiometal directly to the nanoparticle itself without the need of such agents. We previously demonstrated that direct radiolabeling of silica nanoparticles with hard, oxophilic ions, such as the positron emitters zirconium-89 and gallium-68, is remarkably efficient. However, softer radiometals, such as the widely employed copper-64, do not stably bind to the silica matrix and quickly dissociate under physiological conditions. Here, we overcome this limitation through the use of silica nanoparticles functionalized with a soft electron-donating thiol group to allow stable attachment of copper-64. This approach significantly improves the stability of copper-64 labeled thiol-functionalized silica nanoparticles relative to native silica nanoparticles, thereby enabling in vivo PET imaging, and may be translated to other softer radiometals with affinity for sulfur. The presented approach expands the application of silica nanoparticles as a platform for facile radiolabeling with both hard and soft radiometal ions.

Indexed as

Silicon DioxideAnimalsCopper RadioisotopesMaleMice, NudeNanoparticlesPositron-Emission TomographySulfurCopper RadioisotopesSilicon DioxideSulfurPET imagingradiolabelingsilica nanoparticlessurface functionalization

Identifiers

PMID27464258
PMCPMC5066563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.